20n Bio: Funding, Investors & Team (Sep 2026)
20n Bio (pr. "twenty-n bio") is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics. Launched in 2021 and located in Malvern PA, 20n Bio's mission is addressing unmet medical needs by leveraging high-throughput screening and computing to develop peptide drugs with desired biophysical, functional, and pharmacological properties.
20n Bio has raised $7.5M across 1 funding round on record, the most recent a Seed of $7.5M announced in May 2026.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
20n Bio Company Profile and Key Stats
Latest funding round on record: May 2026.
20n Bio Funding Rounds
20n Bio Founders and Leadership Team
Contact details for the 20n Bio team: 1 has a LinkedIn profile.
Start 14-day free trial →20n Bio Funding Compared to Other Biotechnology Startups
20n Bio's latest round of $7.5M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like 20n Bio in Biotechnology and Malvern
Companies Similar to 20n Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
20n Bio Funding FAQs
What does 20n Bio do?
20n Bio (pr. "twenty-n bio") is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics. Launched in 2021 and located in Malvern PA, 20n Bio's mission is addressing unmet medical needs by leveraging high-throughput screening and computing to develop peptide drugs with desired biophysical, functional, and pharmacological properties.
How much funding has 20n Bio raised?
20n Bio has raised $7.5M across 1 round on record. The most recent is a Seed of $7.5M announced in May 2026.
When did 20n Bio last raise funding?
20n Bio's most recent funding round on record is a Seed of $7.5M, announced in May 2026.
Who founded 20n Bio?
FundedIQ lists Mingfu Zhu (Founder) at 20n Bio.
Where is 20n Bio headquartered?
20n Bio is based in Malvern, Pennsylvania, United States.
How many employees does 20n Bio have?
20n Bio is in the 1-10 employee band.
How does 20n Bio's funding compare to other Biotechnology startups?
20n Bio's latest round of $7.5M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's 20n Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for 20n Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.